Related Experiment Video
Updated: Feb 8, 2026

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
Published on: June 7, 2015
Validation of Delivery Consistency for Intensity-Modulated Radiation Therapy and Volumetric-Modulated Arc Therapy
Wui Ann Woon1,2, Paul B Ravindran2,3, Piyasiri Ekayanake2
1Department of Radiation Oncology, The Brunei Cancer Center, Bandar Seri Begawan, Brunei Darussalam.
The Varian Edge linear accelerator consistently delivers intensity-modulated radiation therapy (IMRT) and volumetric-modulated arc therapy (VMAT) plans for nasopharynx carcinoma and prostate cancer. Electronic portal imaging device and trajectory log files confirmed high accuracy, unlike other commercial systems.
Area of Science:
- Medical Physics
- Radiation Oncology
- Radiotherapy Technology
Background:
- Nasopharynx carcinoma (NPC) and prostate cancer treatments often utilize intensity-modulated radiation therapy (IMRT) and volumetric-modulated arc therapy (VMAT).
- Ensuring consistent dose delivery from linear accelerators throughout lengthy treatment courses is critical for patient outcomes.
- Evaluating the reliability of various quality assurance (QA) systems for advanced radiotherapy techniques is essential.
Purpose of the Study:
- To investigate the delivery consistency of a Varian Edge linear accelerator for IMRT and VMAT plans in NPC and prostate cancer.
- To compare the accuracy of different measurement systems (EPID, MapCheck2, ArcCheck, log files) for daily QA.
- To assess the long-term reliability of the Varian Edge 120 HD MLC for complex treatment deliveries.
Main Methods:
- Four distinct methods were employed to assess delivery consistency over 34 (NPC) and 29 (prostate) days.
- Measurements included electronic portal imaging device (EPID), MapCheck2, and ArcCheck systems, with gamma analysis against patient-specific QA.
- In-house software analyzed daily log files to reconstruct delivered doses, comparing them to planned doses.
Main Results:
- Trajectory log file and EPID methods demonstrated excellent agreement with minimal daily dose deviations.
- MapCheck2 and ArcCheck systems showed statistically significant differences (P < 0.001) compared to EPID, indicating greater daily fluctuations.
- Concerns were raised regarding the performance and reliability of MapCheck2 and ArcCheck for identifying dosimetric inaccuracies in IMRT/VMAT plans.
Conclusions:
- The Varian Edge linear accelerator with a 120 HD MLC consistently delivers IMRT and VMAT plans throughout extended treatment courses.
- EPID and trajectory log file analysis are reliable methods for verifying daily dose delivery accuracy.
- Further investigation is needed into the discrepancies observed with MapCheck2 and ArcCheck systems for advanced radiotherapy QA.
More Related Videos
07:57Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
Published on: March 24, 2022
08:34Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
Related Concept Videos
Gene Therapy
Group Therapy
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Behavior Therapy
Exposure therapy is a cornerstone of behavioral treatment for anxiety disorders. It involves systematic exposure to feared stimuli, either in real...
Drug Therapy
Antianxiety Medications
Cognitive Therapy